Literature DB >> 25431969

Bioinformatics analysis of gene expression profiles in childhood B-precursor acute lymphoblastic leukemia.

Jun Li, Xiaowen Zhai, Hongsheng Wang, Xiaowen Qian, Hui Miao, Xiaohua Zhu.   

Abstract

OBJECTIVES: To explore the underlying molecular mechanisms of childhood B-precursor acute lymphoblastic leukemia (ALL) by bioinformatics analysis and find potential targets for childhood ALL diagnosis and treatment.
METHODS: Gene expression profile GSE28460 was downloaded from the Gene Expression Omnibus, including 49 diagnostic and relapse bone marrow samples with childhood B-precursor ALL. The differentially expressed genes (DEGs) were identified by paired t-test. Pathway enrichment analysis of DEGs and transcription factors (TFs) enrichment analysis were performed, followed by construction of co-expressed, DEGs, and susceptibility gene protein-protein interaction (PPI) network. Based on these three networks, relevant regulatory network modules and the important DEGs in the modules were identified.
RESULTS: Total of 947 DEGs were identified. Up-regulated DEGs enriched 20 pathways including cell cycle, and down-regulated DEGs significantly enriched Jak-STAT signaling pathways. CDK1 and BRCA1 were found to have more hubs in both co-expressed network and PPI network. Besides, total of five modules in INTS10, MCM, BRCA1, GYPA, and VCAN1 families were identified and a pathway of INTS10-INTS6-POLR2A-MAGI2 was selected.
CONCLUSION: Cell cycle and Jak-STAT signaling pathway were closely associated with relapse of childhood B-precursor ALL. The DEGs, such as PTTG1, PIK3CA, CDK1, and BRCA1 may be the potential targets for childhood ALL diagnosis and treatment.

Entities:  

Keywords:  Acute lymphoblastic leukemia; Bioinformatics analysis; Molecular mechanism; Network module

Mesh:

Substances:

Year:  2014        PMID: 25431969     DOI: 10.1179/1607845414Y.0000000214

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  6 in total

Review 1.  Genomic regulation of transcription and RNA processing by the multitasking Integrator complex.

Authors:  Sarah A Welsh; Alessandro Gardini
Journal:  Nat Rev Mol Cell Biol       Date:  2022-09-30       Impact factor: 113.915

2.  An improved advanced fragment analysis-based classification and risk stratification of pediatric acute lymphoblastic leukemia.

Authors:  Yanran Sun; Qiaosheng Zhang; Guoshuang Feng; Zhen Chen; Chao Gao; Shuguang Liu; Ruidong Zhang; Han Zhang; Xueling Zheng; Wenyu Gong; Yadong Wang; Yong Wu; Jie Li; Huyong Zheng
Journal:  Cancer Cell Int       Date:  2019-04-25       Impact factor: 5.722

3.  The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer.

Authors:  Stephin J Vervoort; Sarah A Welsh; Jennifer R Devlin; Elisa Barbieri; Deborah A Knight; Sarah Offley; Stefan Bjelosevic; Matteo Costacurta; Izabela Todorovski; Conor J Kearney; Jarrod J Sandow; Zheng Fan; Benjamin Blyth; Victoria McLeod; Joseph H A Vissers; Karolina Pavic; Ben P Martin; Gareth Gregory; Elena Demosthenous; Magnus Zethoven; Isabella Y Kong; Edwin D Hawkins; Simon J Hogg; Madison J Kelly; Andrea Newbold; Kaylene J Simpson; Otto Kauko; Kieran F Harvey; Michael Ohlmeyer; Jukka Westermarck; Nathanael Gray; Alessandro Gardini; Ricky W Johnstone
Journal:  Cell       Date:  2021-05-17       Impact factor: 66.850

4.  Pan-Cancer Mutational and Transcriptional Analysis of the Integrator Complex.

Authors:  Antonio Federico; Monica Rienzo; Ciro Abbondanza; Valerio Costa; Alfredo Ciccodicola; Amelia Casamassimi
Journal:  Int J Mol Sci       Date:  2017-04-29       Impact factor: 5.923

5.  Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer.

Authors:  Wookyeom Yang; Hanbyoul Cho; Ha-Yeon Shin; Joon-Yong Chung; Eun Suk Kang; Eun-Ju Lee; Jae-Hoon Kim
Journal:  Oncotarget       Date:  2016-08-02

6.  In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1.

Authors:  Harshita Nivrutti Khedkar; Yu-Chi Wang; Vijesh Kumar Yadav; Prateeti Srivastava; Bashir Lawal; Ntlotlang Mokgautsi; Maryam Rachmawati Sumitra; Alexander T H Wu; Hsu-Shan Huang
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.